IL1B and rheumatoid arthritis: Anakinra is a human IL-1 receptor antagonist that acts by competitively inhibiting the binding of IL-1 with the IL-1 type 1 receptor; currently approved for the treatment of RA, cryopyrin-associated periodic syndromes, and Still’s disease [24].